Inventor · disambiguated record
Claudio Giuliano
Also filed as: GIULIANO CLAUDIO
22 granted patents·4 pending applications·86 citations·filing 1988–2025
94Inventor score
Files withHELSINN HEALTHCARE SA19FADINI LUCA2ANGELETTI P IST RICHERCHE BIO1GARCIA RUBIO SILVINA1ISTITUTO DI RICERCHE BIOLOG MOLECOLARE P ANGELETTI SPA1
Top patents by PatentIndex Score
26 records- 0194US8426450B1Substituted 4-phenyl pyridines having anti-emetic effectFADINI LUCA·Filed 2012·Granted Apr 23, 2013·22 cites·3 claims
- 0289US10208073B2Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2018·Granted Feb 19, 2019·2 cites·13 claims
- 0385US9403772B24-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2012·Granted Aug 2, 2016·4 cites·14 claims
- 0485US7091209B2Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitorsANGELETTI P IST RICHERCHE BIO·Filed 2001·Granted Aug 15, 2006·22 cites·16 claims
- 0583US9546157B2Asymmetric piperidinyl-substituted ureas as medicinesHELSINN HEALTHCARE SA·Filed 2015·Granted Jan 17, 2017·4 cites·38 claims
- 0681US12440485B2Centrally-active ghrelin agonist and medical uses thereofHELSINN HEALTHCARE SA·Filed 2024·Granted Oct 14, 2025·0 cites·28 claims
- 0780US8658797B2Asymmetric ureas and medical uses thereofGARCIA RUBIO SILVINA·Filed 2012·Granted Feb 25, 2014·7 cites·19 claims
- 0879US12071421B2Process for the synthesis of substituted chloromethyl dialkylphosphatesHELSINN HEALTHCARE SA·Filed 2022·Granted Aug 27, 2024·0 cites·3 claims
- 0979US10577384B2Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2018·Granted Mar 3, 2020·2 cites·15 claims
- 1079US8012982B2Modulators of HCV replicationISTITUTO DI RICERCHE BIOLOG MOLECOLARE P ANGELETTI SPA·Filed 2005·Granted Sep 6, 2011·6 cites·7 claims
- 1178US12005056B2Centrally-active ghrelin agonist and medical uses thereofHELSINN HEALTHCARE SA·Filed 2019·Granted Jun 11, 2024·2 cites·22 claims
- 1278US9926337B2Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 27, 2018·2 cites·19 claims
- 1377US2025367181A1Centrally-Active Ghrelin Agonist and Medical Uses ThereofHELSINN HEALTHCARE SA·Filed 2025·Application pending·0 cites
- 1476US10407390B2Asymmetric ureas and medical uses thereofHELSINN HEALTHCARE SA·Filed 2017·Granted Sep 10, 2019·1 cites·3 claims
- 1575US11312698B2Fosnetupitant chloride hydrochloride having improved stabilityHELSINN HEALTHCARE SA·Filed 2020·Granted Apr 26, 2022·0 cites·12 claims
- 1671US10717721B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2018·Granted Jul 21, 2020·0 cites·2 claims
- 1770US11884646B2Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereofHELSINN HEALTHCARE SA·Filed 2022·Granted Jan 30, 2024·0 cites·27 claims
- 1867US9908907B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 1964US8895586B2Methods of treating emesisFADINI LUCA·Filed 2013·Granted Nov 25, 2014·0 cites·21 claims
- 2063US2020262850A1Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2020·Application pending·0 cites
- 2160US9751836B2Asymmetric ureas and medical uses thereofHELSINN HEALTHCARE SA·Filed 2014·Granted Sep 5, 2017·0 cites·49 claims
- 2259US2025205216A2Piperidine Urea Derivatives for Use as Inotropic AgentsLUND LARS·Filed 2022·Application pending·0 cites
- 2356US11299472B2Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereofHELSINN HEALTHCARE SA·Filed 2018·Granted Apr 12, 2022·0 cites·22 claims
- 2456US2024000791A1Methods of Using 4-Amino-N-[4-(Methoxymethyl)Phenyl]-7-(1-Methylcyclopropyl)-6-(3-Morpholinoprop-1-YN-1-YL)-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carboxamide for the Treatment of TumorsHELSINN HEALTHCARE SA·Filed 2021·Application pending·0 cites
- 2546US4923354AMagazine with movable shelves, for the maturation of cakes of synthetic foam materialTOSCANA GOMMA GEST RIUNITE·Filed 1988·Granted May 8, 1990·12 cites·5 claims
- 2639US10501479B2Benzenesulfonyl-asymmetric ureas and medical uses thereofHELSINN HEALTHCARE SA·Filed 2017·Granted Dec 10, 2019·0 cites·51 claims
Join the waitlist — get patent alerts
Get an alert when Claudio Giuliano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →